AMP INC
S-3, 1997-01-10
ELECTRONIC CONNECTORS
Previous: AMERICAN RECREATION CENTERS INC, 10-Q, 1997-01-10
Next: BASSETT FURNITURE INDUSTRIES INC, DEF 14A, 1997-01-10



 





   As filed with the Securities and Exchange Commission on January 10, 1997
            Registration No.333-         
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549
                                               
                                 FORM S-3
                          REGISTRATION STATEMENT
                                   UNDER
                        THE SECURITIES ACT OF 1933
                                               
                             AMP Incorporated
            (Exact name of registrant as specified in charter)
   Pennsylvania             470 Friendship Road           23-033-2575
                      Harrisburg, Pennsylvania 17111
                              (717) 564-0100
   (State or other            (Address, including         (I.R.S.
   jurisdiction of            zip code, and               Employer
   incorporation or           telephone number,           Identification
   organization)              including area code,        No.)
                              of registrant's principal 
                              executive offices)       
    
                             David F. Henschel
                             AMP Incorporated
                            470 Friendship Road
                      Harrisburg, Pennsylvania 17111
                              (717) 564-0100
         (Name, address, including zip code, and telephone number,
                including area code, of agent for service.)

                                Copies to:

   David W. Schoenberg, Esq.                    Joseph L. Johnson III, Esq.
   Altheimer & Gray                             Goodwin, Procter & Hoar
   10 South Wacker Drive, Suite 4000            Exchange Place
   Chicago, Illinois 60606                      Boston, Massachusetts 02109
   (312) 715-4000                               (617) 570-1000

            Approximate date of commencement of proposed sale to the
   public:  As soon as practicable after this Registration Statement
   becomes effective.

            If the only securities being registered on this Form are
   being offered pursuant to dividend or interest reinvestment plans,
   please check the following box:  / /
            If any of the securities being registered on this Form are
   to be offered on a delayed or continuous basis pursuant to Rule 415
   under the Securities Act of 1933, other than securities offered only
   in connection with dividend or interest reinvestment plans, check the
   following box:  / /
            If this Form is filed to register additional securities for
   an offering pursuant to Rule 462(b) under the Securities Act, please <PAGE>
 
   <PAGE>
   check the following box and list the Securities Act registration
   statement number of the earlier effective registration statement for
   the same offering: / /
            If this Form is a post-effective amendment filed pursuant to
   Rule 462(c) under the Securities Act, check the following box and
   list the Securities Act registration statement number of the earlier
   effective registration statement for the same offering: / /
            If delivery of the prospectus is expected to be made
   pursuant to Rule 434, please check the following box: / /
   <TABLE>
   <CAPTION>
                     CALCULATION OF REGISTRATION FEE

   Title of Each Class  Amount      Proposed    Proposed      Amount of
   of Securities        to be       Maximum     Maximum       Registra
   to be Registered     Registered  Offering    Aggregate     tion Fee
                                    Price Per   Offering
                                    Unit (1)    Price (1)
   <S>                  <C>         <C>         <C>           <C>
   Common Stock, no      995,608     $38.375     $38,206,457   $13,180
   par value
   </TABLE>
   (1)   Estimated in accordance with Rule 457 of Regulation C under the
         Securities Act of 1933, as amended, solely for the purpose of
         determining the registration fee.  The above calculation is
         based on the average of the high and low prices of the Common
         Stock reported on the NYSE Composite Tape on January 3, 1997.

            The registrant hereby amends this Registration Statement on
   such date or dates as may be necessary to delay its effective date
   until the registrant shall file a further amendment which
   specifically states that this Registration Statement shall thereafter
   become effective in accordance with Section 8(a) of the Securities
   Act of 1933, as amended or until the Registration Statement shall
   become effective on such date as the Commission, acting pursuant to
   such Section 8(a), may determine.
   <PAGE>
               SUBJECT TO COMPLETION, DATED JANUARY 10, 1997
   PROSPECTUS
              , 1997
                               995,608 Shares

                              AMP INCORPORATED
                               Common Stock 

            Of the 995,608 shares of common stock, no par value ("Common
   Stock"), of AMP Incorporated, a Pennsylvania corporation (the
   "Company"), offered hereby, 486,844 shares are being offered by
   Robert M. Bretholtz ("RMB"), 234,175 shares are being offered by the
   Harold N. Cotton Trust ("HNC"), 34,240 shares are being offered by
   the Joshua B. Bretholtz Grantor Trust ("JBBGT"), 61,331 shares are
   being offered by the Nancy E. Cotton 1995 Trust ("NCT"), 61,331
   shares are being offered by the Betsy L. Cotton 1995 Trust ("BCT"), <PAGE>
 
   <PAGE>
   61,331 shares are being offered by the Lauren A. Cotton 1995 Trust
   ( LCT ), 34,240 shares are being offered by the Jared S. Bretholtz
   Grantor Trust ("JSBGT"), 7,372 shares are being offered by the Harold
   N. Cotton GST FBO Betsy Cotton ("GSTBC"), 7,372 shares are being
   offered by the Harold N. Cotton GST FBO Lauren Cotton ("GSTLC"), and
   7,372 shares are being offered by the Harold N. Cotton GST FBO Nancy
   Cotton ("GSTNC") (RMB, HNC, JBBGT, NCT, BCT, LCT, JSBGT, GSTBC, GSTLC
   and GSTNC, collectively the "Selling Shareholders").  See "Selling
   Shareholders" and "Plan of Distribution."

            The Common Stock to be sold by the Selling Shareholders was
   issued in connection with the acquisition by a wholly-owned
   subsidiary of the Company of Madison Cable Corporation, Madison Cable
   Limited and the net assets of Airport Realty Company and Jared
   Associates (the "Acquisition").  The Company has agreed with the
   Selling Shareholders or their affiliates to register the 1,610,047
   shares of Common Stock issued to date in the Acquisition, which
   shares include the 995,608 shares of Common Stock offered hereby. 
   The Company has also agreed to pay certain fees and expenses incident
   to such registration.  It is estimated that the fees and expenses
   payable by the Company in connection with the registration of the
   Common Stock will be approximately $30,000.  The Company intends to
   keep the registration statement, of which this Prospectus is a part,
   effective until no later than February 14, 1996.  See "Selling
   Shareholders" and "Plan of Distribution."

            The Company's Common Stock is listed on the New York Stock
   Exchange (the "NYSE"), the Boston Stock Exchange, the Cincinnati
   Stock Exchange, the Midwest Stock Exchange, Inc., the Pacific Stock
   Exchange, Incorporated and the Philadelphia Stock Exchange, Inc. and
   options with respect to the Common Stock are listed on the Chicago
   Stock Exchange, Inc., all under the symbol AMP.  On January 9, 1996,
   the last reported sale price of the Company's Common Stock on the
   NYSE Composite Tape was $41.00 per share.

            The Selling Shareholders directly, through agents designated
   from time to time, or through dealers or underwriters also to be
   designated, may sell the shares of Common Stock being offered hereby
   from time to time on the NYSE, any other securities exchange on which
   the Common Stock is listed or the over the counter market, at prices
   and on terms then prevailing thereon, or in negotiated transactions
   or otherwise.  To the extent required, the specific number of shares
   to be sold, the names of the Selling Shareholder(s), the respective
   purchase prices and public offering prices, the names of any agents,
   dealers or underwriters, and any applicable commissions or discounts
   with respect to a particular offer will be set forth in an
   accompanying Prospectus Supplement or in an amendment to the
   registration statement of which this Prospectus is a part, as
   appropriate.  See "Plan of Distribution."  Each of the Selling
   Shareholders reserves the sole right to accept and, together with its
   agents from time to time, to reject in whole or in part any proposed
   purchase of shares of Common Stock to be made directly or through
   agents. <PAGE>
 
   <PAGE>
            The Selling Shareholders and any broker-dealers, agents or
   underwriters that participate with the Selling Shareholders in the
   distribution of the shares of Common Stock may be deemed to be
   "underwriters" within the meaning of the Securities Act of 1933, as
   amended (the "Securities Act"), and any commissions received by them
   and any profit on the resale of shares of Common Stock purchased by
   them may be deemed to be underwriting commissions or discounts under
   the Securities Act.  See "Plan of Distribution" herein for
   indemnification arrangements among the Company and the Selling
   Shareholders.

       THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
         SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
               COMMISSION NOR HAS THE SECURITIES AND EXCHANGE
               COMMISSION OR ANY STATE SECURITIES COMMISSION
                  PASSED UPON THE ACCURACY OR ADEQUACY OF
                    THIS PROSPECTUS.  ANY REPRESENTATION
                   TO THE CONTRARY IS A CRIMINAL OFFENSE.

   The date of this Prospectus is             , 1997



   Information contained herein is subject to completion or amendment.
   A registration statement relating to these securities has been filed
   with the Securities and Exchange Commission.  These securities may not
   be sold nor may offers to buy be accepted prior to the time the
   registration statement becomes effective.  This prospectus shall not
   constitute an offer to sell or the solicitation of an offer to buy nor
   shall there be any sale of these securities in any State in which such
   offer, solicitation or sale would be unlawful prior to registration
   or qualification under the securites laws of any such State.
   <PAGE>
            No dealer, salesperson or any other person is authorized to
   give any information or make any representations in connection with
   the offering other than those contained in this Prospectus, and if
   given or made, such information or representations must not be relied
   upon as having been authorized by the Company.  This Prospectus does
   not constitute an offer to sell or solicitation of an offer to buy by
   anyone in any jurisdiction in which such offer to sell or
   solicitation is not authorized, or in which the person making such
   offer is not qualified to do so or to any person to whom it is
   unlawful to make such offer or solicitation.  Neither the delivery of
   this Prospectus nor any sale made hereunder shall, under any
   circumstances, create any implication that there has been no change
   in the affairs of the Company since the date hereof or that the
   information contained herein is correct as of any time subsequent to
   the date hereof. 


                    DOCUMENTS INCORPORATED BY REFERENCE

            The following documents have been filed with the Securities
   and Exchange Commission (the "Commission") under the Securities
   Exchange Act of 1934, as amended (the "Exchange Act"), and are
   incorporated herein by reference:

            (1)   the Annual Report on Form 10-K of the Company for the
   year ended December 31, 1995; 

            (2)   the Quarterly Report on Form 10-Q of the Company for
   the quarter ended March 31, 1996;

            (3)   the Quarterly Report on Form 10-Q of the Company for
   the quarter ended June 30, 1996; <PAGE>
 
   <PAGE>
            (4)   the Quarterly Report on Form 10-Q of the Company for
   the quarter ended September 30, 1996;

            (5)   the Current Report on Form 8-K of the Company filed
   January 2, 1997;

            (6)   the Current Report on Form 8-K of the Company filed
   January 8,1997;

            (7)   the description of the Common Stock contained in the
   Company's Registration Statement on Form 8-B (File No. 1-4235) filed
   on April 10, 1989, and any amendment or report filed for the purpose
   of updating any such description; and

            (8)   the description of the rights under the Rights
   Agreement between the Company and Chemical Bank, dated as of October
   25, 1989 (the "Rights Agreement"), set forth in the Company's
   Registration Statement on Form 8-A (File No. 1-4235) filed on
   November 7, 1989, and any amendment or report filed for the purpose
   of updating any such description.

            All documents and reports filed by the Company pursuant to
   Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to
   the date of this Prospectus and prior to the termination of the
   offering of the shares of Common Stock pursuant hereto shall be
   deemed to be incorporated by reference herein and to be a part hereof
   from the date of filing of such documents.  

            Any statement contained in a document incorporated or deemed
   to be incorporated by reference herein shall be deemed to be modified
   or superseded for the purposes of this Prospectus to the extent that
   a statement contained herein or in any other subsequently filed
   document which also is or is deemed to be incorporated by reference
   herein modifies or supersedes such statement.  Any such statement so
   modified or superseded shall not be deemed, except as so modified or
   superseded, to constitute a part of this Prospectus.

            The Company will provide without charge to each person to
   whom this Prospectus has been delivered, upon written or oral
   request, a copy of any or all of the documents referred to above
   which have been or may be incorporated by reference herein, other
   than exhibits to such documents (unless such exhibits are
   specifically incorporated by reference therein).  Requests for such
   copies should be directed to AMP Incorporated, P.O. Box 3608, Mail
   Stop 176-48, Harrisburg, Pennsylvania 17105, Attention: David F.
   Henschel, Corporate Secretary, telephone number (717) 564-4205.
   <PAGE>
                                THE COMPANY

            AMP is the world leader in electrical and electronic
   connection devices and a producer of an expanding number of connector
   intensive assemblies and total interconnection systems.  AMP supplies
   over 100,000 types and sizes of terminals, splices, connectors, cable
   and panel assemblies, electro-optic devices, printed circuit board <PAGE>
 
   <PAGE>
   assemblies, sensors, wide and local area network products and
   systems, switches, touch screen data entry systems and related
   application tooling to more than 250,000 worldwide customer
   locations, including original electrical and electronic equipment
   manufacturers and customers who install and maintain that equipment. 
   The mailing address of AMP's principal executive offices is P.O. Box
   3608, Mail Stop 176-40, Harrisburg, Pennsylvania 17105, and its
   telephone number is (717) 564-0100.

                        DESCRIPTION OF CAPITAL STOCK

            The class of securities to be registered is Common Stock, no
   par value.

   Capital Stock

            The following statements with respect to the Company's
   capital stock are subject to the detailed provisions of the Company's
   Restated Articles of Incorporation ("Articles of Incorporation"),
   By-laws, as amended (the "By-laws"), and the Rights Agreement.  These
   statements do not purport to be complete and are qualified in their
   entirety by reference to the terms of the Articles of Incorporation,
   the By-laws and the Rights Agreement, each of which are incorporated
   by reference into this Prospectus.

            The Company is authorized to issue 700,000,000 shares of its
   Common Stock.  The Company has no other authorized classes of stock
   or securities.  As of December 30, 1996, 219,575,661 shares of Common
   Stock were issued and outstanding (excluding 12,920,468 shares held
   in treasury).  

   Common Stock

            Each share of Common Stock of the Registrant entitles the
   holder thereof to one vote on all matters submitted to a vote of the
   shareholders.  In electing directors, shareholders are not entitled
   to cumulative voting.  Holders of Common Stock do not have any
   preemptive rights or rights to subscribe to additional securities of
   the Company.  There are no conversion rights, redemption provisions
   or sinking fund provisions applicable to the Common Stock nor is it
   subject to calls or assessments by the Company.  Upon liquidation,
   the holders of the Common Stock are entitled to receive, pro rata,
   the net assets of the Company available for distribution to
   shareholders.  Holders of Common Stock are entitled to share ratably
   in dividends when and as declared by the Board of Directors of the
   Company out of funds legally available therefor.

   Common Stock Purchase Rights

            In 1989, the Company adopted a Shareholder Rights Plan (the
   "Shareholder Rights Plan") and distributed to its shareholders, with
   respect to each outstanding share of Common Stock held, one right
   ("the Right") to purchase one share of Common Stock at a purchase
   price of $175, subject to adjustment.  The purchase price was <PAGE>
 
   <PAGE>
   adjusted to $87.50 to reflect the Company's 2-for-1 stock split
   effected on March 2, 1995.  The description and terms of the Rights
   are set forth in the Rights Agreement.  

            The Rights will remain attached to the Common Stock and are
   not exercisable except under the limited circumstances set forth in
   the Shareholder Rights Plan and relating generally to the acquisition
   of, or tender for, 20% or more of the outstanding Common Stock.  If
   such circumstances occur, the Rights will separate from the Common
   Stock and become exercisable.  If, subsequently, a person actually
   acquires beneficial ownership of 20% or more of the Common Stock (an
   "Acquiring Person"), except pursuant to an offer for all outstanding
   shares of Common Stock which the independent directors of the Company
   determine, after receiving advice from one or more investment banking
   firms, to be fair to and otherwise in the best interests of the
   Company and its shareholders (a "Qualifying Offer"), each Right
   (except those held by such Acquiring Person) will become exercisable
   for such number of shares of Common Stock (or, in certain
   circumstances, a reasonable substitute therefor) having a market
   value equal to twice the exercise price of the Right.  In addition,
   if, after such time as an acquiror of shares of Common Stock becomes
   an Acquiring Person, (i) the Company is acquired in a merger or other
   business combination transaction in which the Company is not the
   surviving corporation (other than a merger which follows a Qualifying
   Offer and satisfies certain other requirements), (ii) the Company is
   acquired in a merger or other business combination transaction in
   which the Company is the surviving corporation but all or part of the
   Common Stock is changed into or exchanged for securities of the other
   person or other property, or (iii) 50% or more of the Company's
   assets, cash flow or earning power is sold or transferred, each Right
   will become exercisable for such number of shares of common stock of
   the acquiror having a value equal to twice the exercise price of the
   Right.  The Rights expire on November 6, 1999 unless earlier redeemed
   by the Company for $.005 per Right.  The Company may redeem the
   Rights at any time until 10 business days after a person has become
   an Acquiring Person.  Until the Rights separate from the Common
   Stock, each new share of Common Stock issued will have a Right
   attached.  The Rights do not have voting or dividend rights and,
   until they become exercisable, have no dilutive effect on the
   earnings of the Company.
   <PAGE>
                            SELLING SHAREHOLDERS

      The following table sets forth certain information with respect to
   the Selling Shareholders, including the number of shares of Common
   Stock beneficially owned by each Selling Shareholder as of the date
   of this Prospectus, the percentage of shares of voting stock
   outstanding held by each and the number of shares of Common Stock
   offered hereby.  There can be no assurance that all or any of the
   shares offered hereby will be sold.
   <PAGE>
   <TABLE>

   <CAPTION>
                                    Percent               Number      Percen <PAGE>
 
                        Number      age of      Number    of          tage
                        of          Shares      of        Shares      of
                        Shares      of          Shares    of          Shares
                        of          Common      of        Common      of
                        Common      Stock       Common    Stock       Common
                        Stock       Outstand    Stock     Benefi      Stock
                        Benefi      ing Prior   Offered   cially      Out
                        cially      to the                Held        stand
                        Held        Offering              After       ing Af
                        Prior to                          the         ter 
   Selling              the                               Offering    the
   Shareholder          Offering                                      Offering

   <S>                  <C>         <C>         <C>       <C>         <C>
   Robert M.             486,844     *          486,844    -           -
   Bretholtz(1)

   Harold N. Cotton      234,175     *          234,175    -           -
   Trust(2)

   Jared S. Bretholtz     34,240     *           34,240    -           -
   Grantor Trust

   Joshua B. Bretholtz    34,240     *           34,240    -           -
   Grantor Trust

   Nancy E. Cotton        61,331     *           61,331    -           -
   1995 Trust(3)

   Betsy L. Cotton        61,331     *           61,331    -           -
   1995 Trust(3)

   Lauren A. Cotton       61,331     *           61,331    -           -
   1995 Trust(3)

   Harold N. Cotton        7,372     *            7,372    -           -
   GST FBO Lauren 
   Cotton(3)

   Harold N. Cotton        7,372     *            7,372    -           -
   GST FBO Betsy 
   Cotton(3)

   Harold N. Cotton        7,372     *            7,372    -           -
   GST FBO Nancy 
   Cotton(3)
                                                                         
                         995,608     *          995,608    -           -
   </TABLE>
   *  Represents less than one percent of the outstanding shares of
   Common Stock.

   (1)      Excludes shares held by the Joshua B. Bretholtz Grantor
      Trust and shares held by the Jared S. Bretholtz Grantor Trust, of <PAGE>
 
   <PAGE>
      which Mr. Bretholtz is the trustee.  Mr. Bretholtz disclaims
      beneficial ownership of such shares.

   (2)      Lauren A. Cotton, Betsy L. Cotton and Nancy E. Cotton are
      the beneficiaries of this trust.  Phyllis J. Cotton, Daniel I.
      Cotton, Melvin M. Rosenblatt and David R. Andelman are the
      trustees of this trust and all disclaim beneficial ownership of
      such shares.

   (3)      Melvin M. Rosenblatt, David R. Andelman and Daniel I. Cotton
     are the trustees of this trust and all disclaim beneficial
     ownership of such shares.

      RMB and JBBGT acquired the shares of Common Stock offered hereby
   on February 28, 1996 from a wholly-owned subsidiary of the Company,
   pursuant to an Acquisition Agreement and Plan of Merger dated as of
   January 10, 1996 by and among the Company, MC Merger Corp., Madison
   Cable Corporation ("Madison Cable"), Madison Cable Limited ("Madison
   Limited"), Airport Realty Company ("Airport Realty"), Jared
   Associates ("Jared") and certain of the Selling Shareholders or their
   affiliates (the "Acquisition Agreement").  Pursuant to the
   Acquisition Agreement, the subsidiary of the Company acquired all of
   the issued and outstanding capital stock of Madison Cable and Madison
   Limited and all of the respective assets of Airport Realty and Jared. 
   Shares received by Harold N. Cotton pursuant to the Acquisition
   Agreement were transferred without consideration to the Harold N.
   Cotton Trust, and were subsequently transferred again without
   consideration to HNC, GSTBC, GSTLC and GSTNC upon Mr. Cotton s death. 
   NCT, BCT, and LCT are indirect transferees for no consideration of
   certain entities that received such shares pursuant to the
   Acquisition Agreement.  JSBGT acquired its shares of Common Stock
   without consideration from Ronnie Bretholtz as Custodian for Jared S.
   Bretholtz (who received such shares pursuant to the Acquisition
   Agreement) when Jared S. Bretholtz reached the age of majority.

      In connection with the Acquisition Agreement, the Company and the
   Selling Shareholders or their affiliates have entered into a
   Registration Rights Agreement pursuant to which the Company has
   agreed, among other things, to file up to three registration
   statements in connection with public offerings of shares of Common
   Stock, including the offering contemplated by this Prospectus, by the
   Selling Shareholders.  This Prospectus is provided pursuant to the
   second such registration.  The first registration statement filed
   pursuant to the Registration Rights Agreement became effective on May
   6, 1996.  Certain of the Selling Shareholders, predecessors of certain 
   other Selling Shareholders, the Jewish Community Endowment Foundation of 
   Worcester and Fidelity Investments Charitable Gift Fund sold 614,439 shares
   of Common Stock pursuant to such first registration.  The shares of Common
   Stock to be offered pursuant thereto which were not sold were deregistered
   June 20, 1996.  
   <PAGE>
                            PLAN OF DISTRIBUTION <PAGE>
 

      The Company will not receive any of the proceeds from this
   offering.  

      The shares of Common Stock offered hereby may be sold from time to
   time in one or more transactions at a fixed offering price, which may
   be changed, or at varying prices determined at the time of sale or at
   negotiated prices.  

      The Selling Shareholders may from time to time offer shares of
   Common Stock offered hereby to or through underwriters, dealers or
   agents, who may receive consideration in the form of discounts and
   commissions; such compensation, which may be in excess of ordinary
   brokerage commissions, may be paid by the Selling Shareholders and/or
   the purchasers of the shares of Common Stock offered hereby for whom
   such underwriters, dealers or agents may act.  Any such dealers or
   agents that participate in the distribution of the shares of Common
   Stock offered hereby may be deemed to be "underwriters" as defined in
   the Securities Act, and any profit on the sale of such shares of
   Common Stock offered hereby by them and any discounts, commissions or
   concessions received by any such dealers or agents might be deemed to
   be underwriting discounts and commissions under the Securities Act. 
   The aggregate proceeds to the Selling Shareholders from sales of the
   Common Stock offered by the Selling Shareholders hereby will be the
   purchase price of such Common Stock less any broker's commissions and
   underwriter's discounts.

      To the extent required by the Securities Act with respect to
   underwritten offerings, the specific shares of Common Stock to be
   sold, the names of the Selling Shareholders, the respective purchase
   prices and public offering prices, the names of the underwriter or
   underwriters, and any applicable commissions or discounts with
   respect to a particular offer will be set forth in an accompanying
   Prospectus Supplement or, if appropriate, a post-effective amendment
   to the Registration Statement of which this Prospectus is a part.
   <PAGE>
      The sale of shares of Common Stock by the Selling Shareholders may
   also be effected from time to time by selling shares directly to
   purchasers or to or through broker-dealers.  In connection with any
   such sales, any such broker-dealer may act as agent for the Selling
   Shareholders or may purchase from the Selling Shareholders all or a
   portion of such shares as principal.  Such sales may be made on the
   NYSE or any exchange on which the shares of Common Stock are then
   traded, in the over-the-counter market, in negotiated transactions or
   otherwise at prices and at terms then prevailing or at prices related
   to the then-current market prices or at prices otherwise negotiated. 
   Shares may also be sold in one or more of the following transactions: 
   (i) block transactions (which may involve crosses) in which a
   broker-dealer may sell all or a portion of such shares as agent but
   may position and resell all or a portion of the block as principal to
   facilitate the transaction; (ii) purchases by any such broker-dealer
   as principal and resale by such broker-dealer for its own account
   pursuant to a Prospectus Supplement; (iii) a special offering, an
   exchange distribution or a secondary distribution in accordance with
   applicable NYSE rules; (iv) ordinary brokerage transactions and <PAGE>
 
  <PAGE>
   transactions in which any such broker-dealer solicits purchasers; (v)
   sales "at the market" to or through a market maker or into an
   existing trading market, on an exchange or otherwise, for such
   shares; and (vi) sales in other ways not involving market makers or
   established trading markets, including direct sales to institutions
   or individual purchasers.  In effecting sales, broker-dealers engaged
   by the Selling Shareholders may arrange for other broker-dealers to
   participate.  Broker-dealers will receive commissions or other
   compensation from the Selling Shareholders in amounts to be
   negotiated immediately prior to the sale that are not expected to
   exceed those customary in the types of transactions involved. 
   Broker-dealers may also receive compensation from purchasers of the
   shares which is not expected to exceed that customary in the types of
   transactions involved.

      The Company will pay substantially all the expenses incurred by
   the Selling Shareholders and the Company incident to the offering and
   sale of the shares of Common Stock offered hereby to the public, but
   excluding any discounts, commissions and fees of underwriters,
   broker-dealers or agents or legal fees incurred by the Selling
   Shareholders.  The Company has agreed to indemnify the Selling
   Shareholders against certain liabilities, including liabilities under
   the Securities Act.

                               LEGAL MATTERS

      The validity of the shares of Common Stock being offered hereby
   will be passed upon for the Company by David F. Henschel, Associate
   General Legal Counsel of the Company.  Mr. Henschel beneficially owns
   shares of Common Stock and holds options to purchase additional
   shares of Common Stock.

                                  EXPERTS

      The consolidated financial statements of the Company incorporated
   herein by reference to the Company's Annual Report on Form 10-K for
   the year ended December 31, 1995 have been audited by Arthur Andersen
   LLP, independent public accountants, as indicated in their report
   with respect thereto, and are incorporated herein by reference in
   reliance upon the authority of said firm as experts in giving said
   report.  

                           AVAILABLE INFORMATION

      The Company is subject to the informational requirements of the
   Exchange Act and in accordance therewith files reports, proxy and
   information statements and other information with the Commission. 
   Reports, proxy and information statements and other information filed
   with the Commission can be inspected and copied during normal
   business hours at the public reference facilities maintained by the
   Commission at Judiciary Plaza, 450 Fifth Street, N.W., Washington,
   D.C. 20549, and at its regional offices at 7 World Trade Center, 13th
   Floor, New York, New York 10048, and Northwestern Atrium Center, 500
   West Madison Street, Suite 1400, Chicago, Illinois 60661.  Copies of <PAGE>
 
   <PAGE>
   such material can be obtained at prescribed rates from the Public
   Reference Section of the Commission, 450 Fifth Street, N.W.,
   Washington, D.C. 20549.  The Commission also maintains a site on the
   World Wide Web at http://www.sec.gov. that contains certain reports,
   proxy statements and other information.  Such reports, proxy and
   information statements, and other information concerning the Company
   can also be inspected at the offices of the NYSE, 20 Broad Street,
   New York, New York 10005, on which exchange shares of Common Stock
   are listed.
   <PAGE>
   Shares of Common Stock are also listed on the following
   regional stock exchanges:  Boston Stock Exchange, Cincinnati Stock
   Exchange, Midwest Stock Exchange, Inc., Pacific Stock Exchange,
   Incorporated and Philadelphia Stock Exchange, and options with
   respect to the Common Stock are listed on the Chicago Stock Exchange,
   Inc.

      This Prospectus constitutes a part of a Registration Statement on
   Form S-3 filed by the Company with the Commission under the
   Securities Act.  This Prospectus omits certain of the information
   contained in the Registration Statement, and reference is hereby made
   to the Registration Statement and to the exhibits thereto for further
   information with respect to the Company and the Common Stock.  Any
   statements contained herein concerning the provisions of any document
   are not necessarily complete, and, in each instance, reference is
   made to the copy of such document filed as an exhibit to the
   Registration Statement or otherwise filed with the Commission.  Each
   such statement is qualified in its entirety by such reference.
   <PAGE>
                                  PART II

                   INFORMATION NOT REQUIRED IN PROSPECTUS

   Item 14.  Other Expenses of Issuance and Distribution.

      Set   forth  below  is  an  estimate  of  the  fees  and  expenses
   anticipated  to be  payable by  the Company,  in connection  with the
   registration and distribution of the Common Stock being registered:


   Securities and Exchange Commission Registration Fee           $13,180
   Legal Fees                                                     14,500
   Accounting Fees                                                 1,500
   Miscellaneous                                                     820
          Total                                                  $30,000


   Item 15.  Indemnification of Directors and Officers.

      The  Company, as  a  Pennsylvania corporation,  is subject  to the
   provisions of the Business Corporation Law of 1988 (the "BCL"), which
   is Pennsylvania's corporation statute.  Subchapter D of Chapter 17 of
   the BCL  provides for the  authority of Pennsylvania  corporations to
   indemnify   directors,   officers,  employees   or   agents   of  the <PAGE>
 
   <PAGE>
   corporation, or of another domestic or foreign corporation for profit
   or  not-for-profit,  partnership,  joint  venture,  trust  or   other
   enterprise (including without limitation,  any employee benefit plan)
   who  are  serving  as   such  at  the  request  of   the  corporation
   (individually,  a  "Representative")   against  expenses   (including
   attorneys'  fees), judgments, fines and amounts paid in settlement in
   the case of third party actions, but only against expenses (including
   attorneys' fees) in the  case of derivative actions.   Unless ordered
   by a  court, such indemnification is to be made only as authorized in
   the specific case upon a determination by the board of directors by a
   majority  vote of  a  quorum consisting  of  directors who  were  not
   parties to the action or proceeding, by the shareholders or, if  such
   quorum  of the  board  is  not  obtainable  or  a  majority  vote  of
   disinterested directors  so  directs, by  independent legal  counsel,
   that  indemnification   of  the  Representative  is   proper  in  the
   circumstances.  Indemnification would be proper if the Representative
   acted in good faith and in a  manner he reasonably believed to be in,
   or  not opposed to, the  best interests of  the corporation and, with
   respect  to any  criminal  proceeding,  had  no reasonable  cause  to
   believe   his  conduct   was   unlawful,  provided   that  under   no
   circumstances would indemnification be proper  in the case of willful
   misconduct or recklessness.

      In the case of  a derivative action, indemnification shall  not be
   made  in respect  of  any  claim,  issue  or matter  as  to  which  a
   Representative has  been adjudged  liable to the  corporation unless,
   and  only to  the  extent that,  a  court of  competent  jurisdiction
   determines  upon  application  that,  despite  the   adjudication  of
   liability,  but in  view  of all  the  circumstances of  the  case, a
   Representative is fairly and reasonably entitled to indemnity for the
   expenses that the court deems proper.

      To the extent a  Representative has been successful on  the merits
   or  otherwise in the defense of a  third party action or a derivative
   action,  indemnification  is  mandatory  with  respect   to  expenses
   (including  attorneys'   fees)  incurred   in  such  defense.     The
   corporation may advance defense expenses (including attorneys'  fees)
   upon receipt of an undertaking by or on  behalf of the Representative
   to repay  such advances if it is ultimately determined that he is not
   entitled to be indemnified, and a  corporation may purchase insurance
   on  behalf  of  any  Representative against  any  liability  asserted
   against him  and incurred by him in any such capacity, or arising out
   of his status as  such, regardless of whether or not  the corporation
   could indemnify him against such  liability.  The indemnification and
   advancement of  expenses  provided under  the  BCL is  expressly  not
   exclusive of any other rights to which a person may be entitled under
   any by-law, agreement, shareholder vote or otherwise.

      Under  the  BCL, limitation  of  director  monetary liability  for
   breach  of fiduciary duty is permitted,  provided that such provision
   is   included  in  a  by-law  approved  by  the  shareholders.    The
   shareholders  of  the Company,  at  the Company s  Annual  Meeting of
   Shareholders held on April 13, 1989, approved such a provision in the
   Company's By-laws.  This provision provides that no director shall be <PAGE>
 
   <PAGE>
   personally liable  for monetary  damages as a  result of  any act  or
   omission, unless he or she has not complied with the standard of care
   statutorily mandated for directors  and his or her acts  or omissions
   constitute self-dealing,  willful misconduct  or  recklessness.   The
   standard of  care  is set  forth  in  Section 2.13  of  the  By-laws,
   entitled "Standard  of Care  and Justifiable Reliance",  and requires
   the director to perform his or her duties  in good faith, in a manner
   he or  she reasonably  believes to  be in the  best interests  of the
   Company, and with such care, including reasonable  inquiry, skill and
   diligence, as a person  of ordinary prudence would use  under similar
   circumstances.  The By-law provision does not apply to liabilities of
   a director pursuant  to any criminal statute or  for payment of taxes
   pursuant to local, state or Federal law.

      On  October  23,  1991, the  Board  of  Directors  of the  Company
   approved  an  amendment to  Article IV  of  the Company's  By-laws to
   provide for  indemnification to the  extent permitted under  the BCL.
   As  amended, Article IV provides that the Company shall indemnify any
   director  or  officer of  the Company,  and  may indemnify  any other
   employee or agent of the Company, who is,  was or becomes a party, or
   is  threatened  to be  made a  party, to  any threatened,  pending or
   completed investigation,  claim, action, suit or  proceeding, whether
   civil, criminal, administrative or investigative, and whether  formal
   or  informal, and  any appeal  therein in  which  any such  person is
   involved (a  "Proceeding") by  reason of  being a Representative,  or
   being  a director, officer, employee or agent of either a constituent
   corporation absorbed in a consolidation or merger or another business
   entity at the  request of such  constituent corporation, against  all
   expenses  (including attorneys'  fees and  disbursements), judgments,
   fines,  and  amounts  paid  in  settlement  actually  and  reasonably
   incurred by such person  in connection with such  proceedings, except
   that in the case of derivative actions, i) indemnification is limited
   to  reasonably incurred  expenses; and  ii) a  person adjudged  to be
   liable  to the Company may not be  indemnified unless and only to the
   extent a court of  competent jurisdiction determines upon application
   that  the person is fairly  and reasonably entitled  to indemnity for
   the  expenses that  such court deems  proper.   Indemnification under
   Article IV  applies to  third party  actions  and derivative  actions
   commenced or  continuing after the  adoption of the  Article, whether
   arising  from  acts  or  omissions  occurring before  or  after  such
   adoption.    Article IV  provides that  the  rights of  directors and
   officers  thereunder   with  respect  to  third   party  actions  are
   contractual rights.

      Article IV  provides that indemnification of  an indemnified party
   under Article IV shall be made by the Company only  when requested in
   writing  with supporting  documentation and,  in accordance  with the
   provisions of the BCL, a determination  is made in each specific case
   that  indemnification  of  the  Representative is  proper  under  the
   circumstances.  Such determination is to be made within 60 days after
   receipt  of  the request  and shall  be made  by  a majority  vote of
   disinterested  directors  (if they  constitute  a  quorum) or,  under
   certain  circumstances, either  by a  written opinion  of independent
   legal counsel or by  the shareholders.  If independent  legal counsel <PAGE>
 
   <PAGE>
   is to make the determination, then the disinterested directors or, if
   the disinterested directors do not constitute a quorum, a majority of
   the  Board of Directors shall select counsel to which the indemnified
   party does not  reasonably object, except that in the  event a change
   of  control as  defined  in  Article  IV  shall  have  occurred,  the
   indemnified  party shall  select counsel  to which  the disinterested
   directors  or, if  the disinterested  directors do  not  constitute a
   quorum,  to  which  a  majority  of the  Board  of  Directors  do not
   reasonably object.  Once a determination is made that the indemnified
   party is entitled  to indemnification, payment  shall be made  within
   five  days thereafter, and such determination shall be binding on the
   Company unless either the  indemnified party made a misrepresentation
   or failed to disclose  a material fact in  requesting indemnification
   and supporting that request, or such indemnification is prohibited by
   law.

      As permitted by the BCL, Article IV also requires that the Company
   advance   reasonable   expenses  to   an   indemnified  party,   upon
   determination by  the Board or its duly  authorized committee, within
   twenty  days after  receipt of  a written  request for  such advance.
   Such  request must  reasonably  identify, describe  and document  the
   legal expenses  actually and  reasonably incurred by  the indemnified
   party and, if required  by law, be  accompanied by an undertaking  of
   the indemnified party to repay the advance if ultimately it should be
   determined  that  the   indemnified  party  is  not  entitled  to  be
   indemnified against such expenses.  The advance may be made upon such
   terms and conditions, if any,  as the Board of Directors or  its duly
   authorized committee deems appropriate.  The financial ability of the
   indemnified  party to make repayment  shall not be  a prerequisite to
   the making of an advance.

      Article  IV  provides  that  an  indemnified  party  shall not  be
   entitled  to indemnification or the advancement of expenses if and to
   the extent 1) the indemnified party did not act in good faith and  in
   a manner the indemnified party  reasonably believed to be in,  or not
   opposed to, the best  interests of the Company  and, with respect  to
   any criminal proceeding, had  reasonable cause to believe his  or her
   conduct was unlawful, or 2)  the Company enters into a contract  with
   the  indemnified  party that  establishes  reasonable limitations  or
   conditions on the indemnification  of and advancement of  expenses to
   the indemnified party and such conditions preclude indemnification or
   advancement  of  expenses under  the  circumstances  at  hand, or  3)
   payment to the indemnified  party would result in double  payment, or
   4)   a  court   of  competent   jurisdiction  determines   that  such
   indemnification  or   advancement  of   expenses  is  unlawful.     A
   termination  of  a third  party Proceeding,  or  any claim,  issue or
   matter therein, by judgment, order, settlement or conviction, or upon
   a plea  of nolo contendere or  its equivalent, shall not,  of itself,
   adversely   affect   the   right   of  the   indemnified   party   to
   indemnification or  create a  presumption that the  indemnified party
   did not meet the condition stated in 1) above.

      In accordance with the BCL, Article IV provides that to the extent
   that an indemnified party is successful on the merits or otherwise in <PAGE>
 
   <PAGE>
   defense of any third party or derivative Proceeding, or in defense of
   any claim,  issue or matter therein,  he or she  shall be indemnified
   against expenses (including attorneys'  fees) actually and reasonably
   incurred  in such  defense.   Moreover, Article  IV provides  that an
   indemnified party shall be  indemnified against any expenses actually
   and reasonably incurred in a successful effort to enforce his  or her
   rights or mandatory  indemnification under applicable  law or his  or
   her rights under  Article IV if the indemnified party prevails in any
   such  enforcement proceeding,  or  on  a  prorated  basis  if  it  is
   determined  that the  indemnified party is  entitled to  receive only
   part of the indemnification or advancement sought.

      Article IV provides that indemnification granted thereunder is not
   exclusive of  any other  rights to  which a  person may otherwise  be
   entitled.  In addition, Article IV provides, as permitted by the BCL,
   that the Company may purchase and maintain insurance on behalf of the
   Company,  its subsidiaries  and affiliates,  and any  Representative,
   against   any  liability  asserted  against  such  Representative  or
   incurred  by such Representative in any such capacity, or arising out
   of said Representative's status  as such, whether or not  the Company
   would  have the power to indemnify such person against that liability
   under  the provisions of applicable law.   The Company may also enter
   into contracts with any  Representative to provide contractual rights
   in  furtherance of  the  provisions of  Article  IV, and  Article  IV
   provides  that  the Company  may  give other  indemnification  to the
   extent not prohibited by applicable law.

      As  provided for  in  Article IV,  the  Company has  entered  into
   indemnification agreements  with each  of its directors  and officers
   and  with  certain  of  its  employees.    These  agreements  contain
   provisions  that afford  rights with  respect to  indemnification and
   advancement of expenses that are consistent with the  authority given
   in Article  IV.  The  Company has also  purchased and  is maintaining
   directors' and  officers' liability insurance covering liabilities to
   directors  or officers of the  Company arising by  reason of wrongful
   acts  committed or allegedly committed  by them, whether  or not they
   are indemnified by the Company.  The cost to the  Company to maintain
   such  insurance  for the  benefit of  its  directors and  officers is
   approximately  $500,000 per year.   The coverage does  not extend to:
   i)  violations of Section 16(b) of the Exchange Act; ii) deliberately
   fraudulent acts  or omissions or  willful violations of  any statute;
   iii)  claims arising  from pollution  or contamination  events unless
   involved  in  a  shareholder   lawsuit  or  derivative  action  under
   circumstances where the  Company does not have  the financial ability
   to provide indemnification or is otherwise not  permitted or required
   to  do so;  iv) claims  brought by  one  director or  officer against
   another  or against the Company,  other than for  claims for wrongful
   termination of employment; and v)  claims arising from bodily injury,
   mental or  emotional distress,  sickness, disease, death  or property
   damage or by reason  of the Employee Retirement Income  Security Act,
   which  types of  claims  are  intended  to  be  covered  under  other
   insurance policies.
   <PAGE>
   Item 16. Exhibits

   Exhibit Number                   Description

      3.1           Restated Articles  of Incorporation  of the  Company
                    (incorporated  by  reference to Exhibit 3.(i).(B) of
                    the Report  on Form 8-K filed  on January 31, 1995).

      3.2           By-laws of  the Company  (incorporated by  reference
                    to Exhibit 3.(ii) of the Annual Report on Form  10-K
                    for  the year  ended  December 31, 1994).

      4.1           Shareholder Rights  Plan  between  the  Company  and
                    Manufacturers   Hanover  Trust   Company,  as Rights
                    Agent, adopted by the  Company's Board of  Directors
                    and  dated  October  25,  1989    (incorporated   by 
                    reference  to Exhibit 4.A  of  the Annual  Report on
                    Form 10-K  for the year ended December 31, 1994).

      4.2           Amendment  to  Shareholder  Rights Plan  between the
                    Company  and Chemical  Bank, as Rights Agent for the
                    Shareholder   Rights  Plan,  dated September 4, 1992
                    (incorporated  by reference  to  Exhibit  4-b of the
                    Annual  Report  on  Form 10-K  for  the  year  ended
                    December 31, 1992).

      5.            Opinion of  David  F.  Henschel,  Associate  General
                    Legal Counsel of the Company, regarding the legality
                    of the shares of Common Stock. 

      23.           Consents of Experts and Counsel.

                    (a)   The consent of Arthur Andersen LLP.
                    (b)   The  consent of  David F. Henschel is included
                          in  his  opinion  filed as Exhibit 5.

      24.           Power of Attorney is included on page II-6.

      99.           Registration Rights  Agreement dated as of  February
                    28, 1996 between the Company and each of the Selling
                    Shareholders (incorporated by  reference to  Exhibit
                    99 to the Registration Statement on Form  S-3  filed
                    on March  26, 1996).


   Item 17.  Undertakings.

      Insofar  as  indemnification  for  liabilities  arising  under the
   Securities Act of  1933 may  be permitted to  directors, officers  or
   controlling  persons  of the  registrant  pursuant  to the  foregoing
   provisions, or otherwise, the registrant has been advised that in the <PAGE>
 
   <PAGE>
   opinion   of   the   Securities    and   Exchange   Commission   such
   indemnification  is  against  public   policy  as  expressed  in  the
   Securities Act and is, therefore, unenforceable.  In the event that a
   claim for  indemnification against  such liabilities (other  than the
   payment by the registrant of expenses incurred or paid by a director,
   officer or  controlling person  of the registrant  in the  successful
   defense  of any  action,  suit or  proceeding)  is asserted  by  such
   director,  officer  or  controlling  person in  connection  with  the
   securities  being  registered, the  registrant  will,  unless in  the
   opinion of its  counsel the  matter has been  settled by  controlling
   precedent, submit to a court of appropriate jurisdiction the question
   whether  such  indemnification by  it  is  against public  policy  as
   expressed  in the  Securities Act and  will be governed  by the final
   adjudication of such issue.

      The undersigned registrant hereby undertakes that:

      (1)   For  purposes  of   determining  any  liability   under  the
            Securities Act of 1933,  the information omitted from the
            form  of prospectus  filed as  part of  this registration
            statement in reliance  upon Rule 430A and  contained in a
            form of  prospectus filed  by the registrant  pursuant to
            Rule 424(b)(1) or (4) or 497(h) under the  Securities Act
            shall be deemed to be part of this registration statement
            as of the time it was declared effective.

      (2)   For  the  purpose of  determining  any  liability under  the
            Securities  Act  of 1933,  each  post-effective amendment
            that  contains a form of prospectus shall be deemed to be
            a new  registration statement relating  to the securities
            offered therein,  and the offering of  such securities at
            that time shall  be deemed  to be the  initial bona  fide
            offering thereof.

      (3)   For   purposes  of  determining   any  liability  under  the
            Securities Act  of 1933, each filing  of the registrant's
            annual report pursuant to  section 13(a) or section 15(d)
            of  the  Securities  Exchange  Act of  1934  (and,  where
            applicable, each  filing of  an  employee benefit  plan's
            annual report pursuant to section 15(d) of the Securities
            Exchange Act  of 1934) that is  incorporated by reference
            in the registration statement shall be deemed to be a new
            registration statement relating to the securities offered
            therein, and the offering of such securities at that time
            shall be  deemed  to be  the initial  bona fide  offering
            thereof.
   <PAGE>
                                 SIGNATURES

      Pursuant  to the requirements of  the Securities Act  of 1933, the
   Registrant certifies that  it has reasonable grounds to  believe that
   it meets all  the requirements for  filing on Form  S-3 and has  duly
   caused this Registration Statement to be  signed on its behalf by the
   undersigned  thereunto duly  authorized, in  the City  of Harrisburg, <PAGE>
 
   <PAGE>
   Commonwealth of Pennsylvania, on the 10th day of January, 1997.


                                    AMP INCORPORATED


                                    By:   /s/ J.E. Marley
                                          James E. Marley
                                          Chairman of the Board




                             POWER OF ATTORNEY

      KNOW  ALL  MEN BY  THESE  PRESENTS,  that  each  individual  whose
   signature appears below constitutes and  appoints James E. Marley and
   David F. Henschel, and each of them, his or her attorneys-in-fact and
   agents, each with the power of substitution for him or her and in his
   or her name, place and stead, in any  and all capacities, to sign any
   and all  amendments  (including post-effective  amendments), to  this
   Registration  Statement,  and to  file  the same,  with  all exhibits
   thereto,  and   all  documents  in  connection   therewith  with  the
   Securities  and   Exchange  Commission,  and  hereby   ratifying  and
   confirming  all that each of said attorneys-in-fact and agents or any
   of them, or their or his or her substitute or substitutes, may  do or
   cause to be done by virtue thereof.

      Pursuant to the requirements  of the Securities Act of  1933, this
   Registration Statement  has been signed  by the following  persons in
   the capacities indicated on January 10, 1997.

   Signature                        Capacity



      /s/ J.E. Marley               Chairman of the Board and a Director
      James E. Marley

   
      /s/ William J. Hudson         Chief Executive Officer and President and
      William J. Hudson             a Director
                                    (Principal Executive Officer)


      /s/ Robert Ripp               Vice President and Chief Financial Officer
      Robert Ripp                   (Principal Financial and Accounting
                                    Officer)

      <PAGE>
      /s/ William S. Urkiel, Jr.   Controller
      William S. Urkiel, Jr.



                                   Director
      Dexter F. Baker         


      /s/ Ralph D. DeNunzio        Director
      Ralph D. DeNunzio       



      /s/ Barbara H. Franklin      Director
      Barbara H. Franklin



      /s/ Joseph M. Hixon          Director
      Joseph M. Hixon



      /s/ J. Magliochetti          Director
      Joseph M. Magliochetti


      /s/ Harold A. McInnes        Director
      Harold A. McInnes


      /s/ J.J. Meyer               Director
      Jerome J. Meyer


      /s/ John C. Morley           Director
      John C. Morley


                                   Director
      Paul G. Schloemer            


                                   Director
      Takeo Shiina                 
   <PAGE>
                             INDEX TO EXHIBITS

     Exhibit                       Description                   Sequentially
     Number                                                         Numbered
                                                                      Page
      3.1         Restated  Articles  of Incorporation  of the
                  Company    (incorporated  by   reference  to
                  Exhibit 3.(i).(B) of the  Report on Form 8-K
                  filed on January 31, 1995). <PAGE>
 
   <PAGE>
      3.2         By-laws  of  the  Company  (incorporated  by
                  reference to   Exhibit 3.(ii)  of the Annual
                  Report  on Form  10-K  for   the year  ended
                  December 31, 1994).

      4.1         Shareholder Rights Plan between  the Company
                  and Manufacturers Hanover Trust  Company, as
                  Rights  Agent,   adopted  by  the  Company's
                  Board of  Directors and  dated   October 25,
                  1989 (incorporated by  reference to  Exhibit
                  4.A of  the Annual  Report on Form  10-K for
                  the year ended December 31, 1994).

      4.2         Amendment to Shareholder Rights Plan between
                  the  Company  and Chemical  Bank,  as Rights
                  Agent for the Shareholder Rights Plan, dated
                  September   4,   1992     (incorporated   by
                  reference  to  Exhibit  4-b  of  the  Annual
                  Report  on  Form  10-K for  the  year  ended
                  December 31, 1992).

       5.         Opinion  of  David  F.  Henschel,  Associate
                  General  Legal  Counsel   of  the   Company,
                  regarding  the  legality  of  the  shares of
                  Common Stock. 

      23.         Consents of Experts and Counsel.

                  (a)   The consent of Arthur Andersen LLP.
                  (b)   The  consent of  David F.  Henschel is
                  included in his opinion filed as Exhibit 5.

      24.         Power of Attorney is included on page II-6.

      99.         Registration  Rights  Agreement dated  as of
                  February  28, 1996  between the  Company and
                  each    of    the    Selling    Shareholders
                  (incorporated by reference  to Exhibit 99 to
                  the Registration Statement on Form S-3 filed
                  on March 26, 1996).


<PAGE> 
   EXHIBIT 5

   January 10, 1997


   AMP Incorporated
   470 Friendship Road
   Harrisburg, Pennsylvania  17111

   Re:      AMP Incorporated
            Registration Statement on Form S-3
            filed January 10, 1997
            (the "Registration Statement")

   Gentlemen:

   I am Associate General Legal Counsel of AMP Incorporated, a
   Pennsylvania corporation (the "Company").  This opinion is being
   furnished to you in connection with the above-referenced Registration
   Statement.  I have examined the Restated Articles of Incorporation of
   the Company, its By-Laws, as amended, minutes of meetings of
   stockholders and directors and such other records and documents as I
   consider necessary for the purposes of rendering this opinion.

   In my opinion:

   The 995,608 shares of Common Stock of the Company covered by the
   Registration Statement have been legally issued and are fully paid
   and non-assessable.

   I hereby consent to the filing of this opinion as an exhibit to the
   Registration Statement and the reference to me under the caption
   "Legal Matters" in the Prospectus contained therein.


   Very truly yours,

   /s/ D.F. Henschel

   David F. Henschel
   Associate General Legal Counsel<PAGE>

<PAGE>
   EXHIBIT 23(a)

                 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

            As independent public  accountants, we hereby consent to the
   incorporation  by reference  in  this Registration  Statement  of our
   report  dated  February  16, 1996  incorporated  by reference  in AMP
   Incorporated's Form  10-K for the year ended December 31, 1995 and to
   all references to our Firm included in this Registration Statement.

                              /s/ Arthur Andersen LLP

   Philadelphia, PA
   January 9, 1997 <PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission